Drug Discovery


Publications
12

CitationNamesAbstract
Evaluation of Candidatus Liberibacter Asiaticus Efflux Pump Inhibition by Antimicrobial Peptides Wang et al. (2022). Molecules 27 (24) Liberibacter
Discovery of novel SecA inhibitors against “ Candidatus Liberibacter asiaticus” through virtual screening and biological evaluation Zhang et al. (2021). Chemical Biology & Drug Design Ca. Liberibacter asiaticus
Amycolatopsis acididurans sp. nov., isolated from peat swamp forest soil in Thailand Teo et al. (2021). The Journal of Antibiotics 74 (3) Amycolatopsis acididurans
Linking metabolic phenotypes to pathogenic traits among “Candidatus Liberibacter asiaticus” and its hosts Zuñiga et al. (2020). npj Systems Biology and Applications 6 (1) Ca. Liberibacter asiaticus
Synthesis of Deoxyradicinin, an Inhibitor of Xylella fastidiosa and Liberibacter crescens, a Culturable Surrogate for Candidatus Liberibacter asiaticus Brandenburg et al. (2020). Journal of Natural Products 83 (6) Ca. Liberibacter asiaticus
Evaluation of Bronopol and Disulfiram as Potential Candidatus Liberibacter asiaticus Inosine 5′-Monophosphate Dehydrogenase Inhibitors by Using Molecular Docking and Enzyme Kinetic Nan et al. (2020). Molecules 25 (10) Ca. Liberibacter asiaticus
Amycolatopsis alkalitolerans sp. nov., isolated from Gastrodia elata Blume Narsing Rao et al. (2020). The Journal of Antibiotics 73 (1) Amycolatopsis alkalitolerans
The endophyte Candidatus Burkholderia crenata of the TCM plant Ardisia crenata produces the selective Gq-inhibitor FR900359 Reher et al. (2016). Planta Medica 81 (S 01) Ca. Burkholderia crenata
In vitro assembly of the bacterial actin protein MamK from ‘ Candidatus Magnetobacterium casensis’ in the phylum Nitrospirae Deng et al. (2016). Protein & Cell 7 (4) Magnetobacterium casense Ts
Identification of small molecule inhibitors against SecA of Candidatus Liberibacter asiaticus by structure based design Akula et al. (2012). European Journal of Medicinal Chemistry 54 Ca. Liberibacter asiaticus